Gene expression programs are fundamental to all living processes. It is now possible to envision mapping the transcriptional regulatory networks that control gene expression programs in living cells. Such maps would be of fundamental value to biologists, and when extended to mammalian cells, might lead to new therapeutic strategies for human diseases. Recently developed technologies allow systematic identification of the genome-wide location of transcriptional regulatory proteins in living cells, and this information can be combined with gene expression and other information to discover transcriptional regulatory networks. We propose to further refine and automate the experimental and computational technologies that enable mapping of transcriptional regulatory networks in living cells. We will use these refined technologies to map the transcriptional regulatory networks that control major biological processes in living yeast cells, and to identify the issues that are key to large scale mapping of mammalian regulatory networks in future studies.
The specific aims of this proposal are: 1) further refine and automate the experimental and analytical technologies that enable efficient mapping of transcriptional regulatory networks in living cells; 2) discover the transcriptional regulatory networks that control major biological processes in yeast, including cell cycle, nutrition, environmental response, genome maintenance, and development; 3) refine technologies necessary for mapping mammalian transcriptional regulatory networks and test them by initiating the mapping of regulatory networks involved in control of human cell cycle.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project (R01)
Project #
1R01HG002668-01
Application #
6561088
Study Section
Special Emphasis Panel (ZRG1-GNM (05))
Program Officer
Feingold, Elise A
Project Start
2003-05-02
Project End
2006-04-30
Budget Start
2003-05-02
Budget End
2004-04-30
Support Year
1
Fiscal Year
2003
Total Cost
$1,671,399
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Iniguez, Amanda Balboni; Stolte, Björn; Wang, Emily Jue et al. (2018) EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. Cancer Cell 33:202-216.e6
Hnisz, Denes; Shrinivas, Krishna; Young, Richard A et al. (2017) A Phase Separation Model for Transcriptional Control. Cell 169:13-23
Suzuki, Hiroshi I; Young, Richard A; Sharp, Phillip A (2017) Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis. Cell 168:1000-1014.e15
Abraham, Brian J; Hnisz, Denes; Weintraub, Abraham S et al. (2017) Small genomic insertions form enhancers that misregulate oncogenes. Nat Commun 8:14385
Weintraub, Abraham S; Li, Charles H; Zamudio, Alicia V et al. (2017) YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell 171:1573-1588.e28
Kalan, Sampada; Amat, Ramon; Schachter, Miriam Merzel et al. (2017) Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors. Cell Rep 21:467-481
Bradner, James E; Hnisz, Denes; Young, Richard A (2017) Transcriptional Addiction in Cancer. Cell 168:629-643
Hnisz, Denes; Young, Richard A (2017) New Insights into Genome Structure: Genes of a Feather Stick Together. Mol Cell 67:730-731
Harmanc?, Akdes Serin; Youngblood, Mark W; Clark, Victoria E et al. (2017) Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun 8:14433
Kaufman, Charles K; Mosimann, Christian; Fan, Zi Peng et al. (2016) A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science 351:aad2197

Showing the most recent 10 out of 101 publications